Fig. 7From: Musashi-2 in cancer-associated fibroblasts promotes non-small cell lung cancer metastasis through paracrine IL-6-driven epithelial-mesenchymal transitionGraphical illustration highlighting our findings that CAFs promote NSCLC invasion and metastasis via MSI2-driven IL-6 secretion. MSI2 is upregulated in CAFs, resulting in IL-6 secretion, which mediates the tumor promoting effect of CAFs via the activation of EMT in NSCLC cells, resulting in tumor metastasis. By contrast, depletion of MSI2 in CAFs inhibited paracrine IL-6, which limits EMT in NSCLC cells, thus preventing NSCLC spreadingBack to article page